Bildkälla: Stockfoto

Egetis Therapeutics: Rights Issue Announced - Redeye

Redeye leaves a comment following Egetis therapeutics’ announcement earlier this morning of a SEK 180 fully guaranteed preferential rights issue.

Redeye leaves a comment following Egetis therapeutics’ announcement earlier this morning of a SEK 180 fully guaranteed preferential rights issue.
Börsvärldens nyhetsbrev
ANNONSER